New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 18, 2013
07:08 EDTBCRXBioCryst advances two kallikrein inhibitors into preclinical development
BioCryst has selected two optimized plasma kallikrein inhibitors to advance into preclinical development as potential once-daily, oral treatments for the prevention of hereditary angioedema attacks.
News For BCRX From The Last 14 Days
Check below for free stories on BCRX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 16, 2014
09:27 EDTBCRXBioCryst management to meet with Needham
Subscribe for More Information
April 14, 2014
10:02 EDTBCRXOn The Fly: Analyst Initiation Summary
Subscribe for More Information
08:08 EDTBCRXBioCryst initiated with an Outperform at Brinson Patrick
Target $15.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use